Could drugs licensed for other conditions help in the treatment of epilepsy?

Posted Jan 3 2019 in Anti-epileptic drugs / Epilepsy general

“Taking a new look at medicines that are already approved for clinical use may help identify treatments that could reduce seizures and improve the quality of life for people with epilepsy who have been unable to find effective therapies,” said Vicky Whittemore, PhD, at the National Institute of Neurological Disorders and Stroke (NINDS).

The development of new drugs is a long, challenging and expensive process and many potential treatments fail along the way before being licensed for treatment.  A potential new medicine may be rejected at any point in the development process on safety, effectiveness or quality grounds.

In this context an attractive option is to look at currently licensed drugs and identifying possible new uses for them; hopefully bringing effective medications to a wider audience.

In a new study, University of Iowa researchers led by Alexander Bassuk, MD, PhD, professor of pediatrics and neurology, used a multidisciplinary strategy to identify a list of around 90 drugs, which are already approved for use, that may also have potential to help control seizures in people with drug resistant epilepsy.

To read more about this research and how the existing 90 drugs were identified as having potential to be used in the treatment for epilepsy, please use the link here: 

 

 

 

News categories